Company: REVB
Filing Date: 2025-09-15
Form Type: 8-K
Source: 0001193125-25-203750
Chunk: 3

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-09-15
Form: 8-K
Item: Item 3.03
Chunk 3
---
Item 3.03 Material Modification to Rights of Security Holders.

To the extent required, the information included in Item 1.01 of this Current Report is hereby incorporated by reference into this Item 3.03.

Item 8.01 Other Events.

On September 11. 2025, the Company issued a press release titled “ Revelation Biosciences, Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds.” A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information in Item 8.01 and in Exhibit 99.1 will not be treated as “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section. This information will not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or into another filing under the Exchange Act, unless that filing expressly incorporates this information by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                
 ──────────────────────────────────────────────────────────────────────────────────────────────
          4.1      Form of Class I Common Stock Warrant                                       
         10.1      Form of Inducement Letter                                                  
         99.1      Press Release dated September 11, 2025                                     
          104      Cover Page Interactive Data File (embedded with the Inline XBRL document)